Prodotto aggiunto correttamente al carrello.

discount label
H-K^AFSPEVIPMF-OH
Visualizzare in 3D

Biosynth logo

H-K^AFSPEVIPMF-OH

Rif. 3D-PP48823

Dimensione non definitaPrezzo su richiesta
Consegna stimata in Stati Uniti, il Mercoledì 06 Novembre 2024

Informazioni sul prodotto

Nome:
H-K^AFSPEVIPMF-OH
Descrizione:

Peptide H-K^AFSPEVIPMF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-K^AFSPEVIPMF-OH include the following: Specificity of CD8+ T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya YS Mohamed , NJ Borthwick , N Moyo, H Murakoshi - Vaccines, 2020 - mdpi.comhttps://www.mdpi.com/2076-393X/8/2/260 Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid XG Yu , M Lichterfeld, S Chetty, KL Williams - Journal of , 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01580-06 HIV-1 Epitope-Specific CD8 V Efficiently - J Immunol, 2006 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=31a987b00fdd46b2369317147f095732d14ff9e1 Strong TCR Conservation and Altered T Cell TD Easterbrook, EY Jones , L Sarah - J , 2006 - erepository.uonbi.ac.kehttp://erepository.uonbi.ac.ke/handle/11295/42340 affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations R Barquera , E Collen, D Di , S Buhler , J Teixeira - Hla, 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/tan.13956 HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome PT Illing , P Pymm , NP Croft , HG Hilton , V Jojic - Nature , 2018 - nature.comhttps://www.nature.com/articles/s41467-018-07109-w HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other PJR Goulder , Y Tang, SI Pelton, BD Walker - Journal of virology, 2000 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.74.11.5291-5299.2000 Published Ahead of Print 22 November 2006. MA Goepfert, PJR Goulder , D Bruce, PK Rosenberg - J. Virol, 2007 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=e9e32fd666a0a0ab67088471f8d485dbc51c37b6 Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules L Fadda, GM O'Connor , S Kumar - Journal of , 2011 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.00412-11 Immunodominance and cross-reactivity of B5703-restricted CD8 T lymphocytes from HIV type 1 subtype C-infected Ethiopians JR Currier, ME Harris, JH Cox - AIDS Research & , 2005 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/aid.2005.21.239 Frequencies of Gag-restricted T-cell escape"footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles J Serwanga, R Nakiboneka, S Mugaba, B Magambo - Vaccine, 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X15002261 Examining the sequence and function of HIV Gag-specific T cell receptors restricted by HLA-B* 57 and HLA-E HSA Hsieh - 2023 - summit.sfu.cahttps://summit.sfu.ca/item/37890 HIV-1 Gag Cytotoxic T Lymphocyte HLN Gall, OO Yang , A Balamurugan, A Ali, J Boucau - J. Virol, 2013 - researchgate.nethttps://www.researchgate.net/profile/Ayub-Ali-2/publication/237060757_HIV-1_Gag_Cytotoxic_T_Lymphocyte_Epitopes_Vary_in_Presentation_Kinetics_Relative_to_HLA_Class_I_Downregulation/links/5447cb980cf22b3c14e1a0fd/HIV-1-Gag-Cytotoxic-T-Lymphocyte-Epitopes-Vary-in-Presentation-Kinetics-Relative-to-HLA-Class-I-Downregulation.pdf Strong TCR conservation and altered T cell cross-reactivity characterize a B* 57-restricted immune response in HIV-1 infection G Gillespie, G Stewart-Jones, J Rengasamy - The Journal of , 2006 - journals.aai.orghttps://journals.aai.org/jimmunol/article/177/6/3893/73891 The Dynamic Interplay between HIV-1 and T cells CR Aguilera-Sandoval - 2016 - search.proquest.comhttps://search.proquest.com/openview/06b6c3a9738c35c5b147162e31d70a2c/1?pq-origsite=gscholar&cbl=18750 High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection CA Jansen, S Kostense - European journal of , 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200425487 Despite biased TRBV gene usage against a dominant HLA B57-restricted epitope, TCR diversity can provide recognition of circulating epitope variants BC Simons, SE VanCompernolle, RM Smith - The Journal of , 2008 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/181/7/5137/84352 Insights into the structure of the LC13 TCR/HLA-B8-EBV peptide complex with molecular dynamics simulations A Stavrakoudis - Cell biochemistry and biophysics, 2011 - Springerhttps://link.springer.com/article/10.1007/s12013-011-9151-2

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP48823 H-K^AFSPEVIPMF-OH

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".